UBX - Unity Biotechnology, Inc Sof marja

Unity Biotechnology (UBX) kompaniyasining rasmiy ramzlari

Unity Biotechnology (UBX) savdo marjalari ko'z patologiyalarini davolash uchun senolitik molekulalar yaratish bo'yicha yetakchining muvaffaqiyatini namoyish etadi. Biznes samaradorligi robotlashtirilgan skrining va tadqiqot ma'lumotlarini dasturiy ta'minot asosida qayta ishlashni joriy etish orqali kuchaytirilgan. Bundan tashqari, qarishga qarshi muolajalarni ishlab chiqish yuqori narx belgilash imkoniyatiga ega eksklyuziv bozor nishasiga kirish imkonini beradi va 0.00 qiymati ushbu ko'rsatkichning joriy metrikasiga mos keladi.

Unity Biotechnology (UBX) Sof marja: 04.07.2022 - 19.07.2025 davri uchun

Unity Biotechnology kompaniyasining tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
Kompaniyaning fundamental tahlili:Unity Biotechnology, Inc, UBX
Unity Biotechnology Inc. ishlab chiqargan mahsulot

Sof foyda marjasi har bir dollar daromadning sof foyda qismini o'lchaydi va operatsion modelning yakuniy samaradorligini belgilaydi. Ushbu koeffitsient investorlarga biznesning real daromad keltirish qobiliyatini baholash orqali beqaror aktivlarni saralab olish imkonini beradi. GURU.Markets platformasida sof foyda marjasi foizini tahlil qilish orqali yashirin haddan tashqari yuqori baholangan risklarni aniqlash mumkin. Unity Biotechnology (UBX) uchun ushbu ko'rsatkich tijorat mahsulotlarining yo'qligi sababli juda muhimdir. Bu yerdagi salbiy narx harakati raqobatchilarga qarshi kurashda klinik sinovlarga sarflangan ulkan xarajatlarni aks ettiradi.

Raqobatdosh kompaniyalar tahlili

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof foyda bo'yicha sotuv rentabelligi NTLA|Stoke Therapeutics Inc (STOK) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi BLFS|Sof marja WVE (Wave Life Sciences Corp)|Sof marja Maze Therapeutics MAZE|Sof foyda normasi SION|PRME - Sof marja|Kompaniya sotuv marjasi Taysha TSHA|QURE: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MeiraGTx PLC|RGNX (REGENXBIO Inc) - Sotuvning sof marjinal rentabelligi|solidbio.com (SLDB) - Kompaniya sotuv marjasi|Sof marja Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Sotuvning sof rentabelligi|Benitec Biopharma - Sof foyda bo'yicha sotuv rentabelligi|DSGN: Sotuvning sof rentabelligi|RCKT: Sof foyda bo'yicha sotuv rentabelligi|FDMT - Sotuvning sof marjinal rentabelligi|LXEO: Sotuvning sof marjinal rentabelligi|Korro Bio Inc. - Sof foyda normasi|EDIT (editasmedicine.com) - Sotuvning sof marjinal rentabelligi|Sof marja SLN|Sof marja ProQR Therapeutics NV (PRQR)|Codexis - Sotuvning sof rentabelligi|Sof marja Sangamo SGMO|NAUT: Sotuvning sof rentabelligi|MGX: Sof foyda bo'yicha sotuv rentabelligi|Sof marja Precision BioSciences|GBIO (generationbio.com) - Sof foyda bo'yicha sotuv rentabelligi|Sof marja boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi IMNN (Imunon, Inc.)|Sotuvning sof marjinal rentabelligi PHIO|MBIO - Sof marja|Sotuvning sof marjinal rentabelligi RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Sof marja|Applied DNA - Sotuvning sof marjinal rentabelligi|Sof marja Bluebird Bio|ImmunoPrecise (IPA) - Sof marja|Sof foyda marjasi OMGA (Omega)|Sof marja Singular Genomics Systems|Sof marja regulusrx.com RGLS|Sof marja Syros Pharmaceuticals Inc. (SYRS)|Kompaniya sotuv marjasi Codex DNA|Sof marja TRACON TCON